Neupogen / Filgrastim

Modified on 2009/10/14 21:51 by admin
Neupogen is manufactured by Amgen Pharmaceuticals and is used to stimulate white blood cell development in cancer patients undergoing chemotherapy. Neupogen is known as a "colony stimulating factor" as it prompts a cancer patient's bone marrow to create white blood cells. Often, chemotherapy has the unwanted side effect of destroying infection fighting white blood cells. When a patient's white blood cell count falls below a certain threshold a Neupogen injection may be administered.

Recently, the FDA and Amgen announced the discovery of counterfeit Neupogen vials. The fake product is labeled as Neupogen® 300 mcg vials in ten-pack boxes. According to the manufacturer, the counterfeit vials examined as of May 10, 2001 contained a clear liquid but no active ingredients. The effect of receiving an injection of the counterfeit Neupogen is unknown, but the manufacturer warns that the fake "may pose a serious health risk to patients."

Additionally, during the summer of 2001, a Kansas City pharmacist was arrested for diluting Neupogen doses that were later given to cancer patients. Pharmacist Robert Courtney faces at least 20 counts of tampering, adulterating, and misbranding a drug.

See your doctor if you believe that you have received counterfeit or diluted Neupogen. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Cancer Drugs: Overview
  Name Size